Skip to main content
SpringerLink
Log in

A report commissioned by the Dutch government says that treatments which cost > euro80 000 for every extra quality-adjusted life year should not be covered

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Sheldon T.Dutch consider excluding costly treatments from health insurance. BMJ 333: 113, No. 7559, 15 Jul 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

A report commissioned by the Dutch government says that treatments which cost > euro80 000 for every extra quality-adjusted life year should not be covered. Pharmacoecon. Outcomes News 508, 3 (2006). https://doi.org/10.2165/00151234-200605080-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200605080-00007

Keywords

Search

Navigation